| Literature DB >> 33994861 |
Yuanzhe Li1, Xiang Li2, Yu Hao2, Yang Liu1,3, ZhiLi Dong1, Kexin Li4.
Abstract
The formation of biofilms on medical-context surfaces gives the EPS embedded bacterial community protection and additional advantages that planktonic cells would not have such as increased antibiotic resistance and horizontal gene transfer. Bacterial cells tend to attach to a conditioning layer after overcoming possible electrical barriers and go through two phases of attachments: reversible and irreversible. In the first, bacterial attachment to the surface is reversible and occurs quickly whilst the latter is permanent and takes place over a longer period of time. Upon reaching a certain density in the bacterial community, quorum sensing causes phenotypical changes leading to a loss in motility and the production of EPS. This position paper seeks to address the problem of bacterial adhesion and biofilm formation for the medical surfaces by comparing inhabiting physicochemical interactions and biological mechanisms. Several physiochemical methodologies (e.g. ultrasonication, alternating magnetic field and chemical surface coating) and utilizing biological mechanisms (e.g. quorum quenching and EPS degrading enzymes) were suggested. The possible strategical applications of each category were suggested and evaluated to a balanced position to possibly eliminate the adhesion and formation of biofilms on medical-context surfaces. © The author(s).Entities:
Keywords: Biofilms adhesion; Biological methods; Medical-context surface; Physicochemical methods; Resistance control.
Mesh:
Substances:
Year: 2021 PMID: 33994861 PMCID: PMC8120469 DOI: 10.7150/ijbs.59025
Source DB: PubMed Journal: Int J Biol Sci ISSN: 1449-2288 Impact factor: 6.580
Figure 1Different inhibition methodologies, signal pathway activities, and EPS actions for biofilm-growth control.
Type of DNase treatment and mode of action against biofilm formation 25,34.
| Bacterium | Type of DNase | Mode of action |
|---|---|---|
| DNase I | Disruption | |
| DNase I | Disruption | |
| DNase I | Disruption | |
| DNase I | Disruption | |
| DNase I | Disruption | |
| DNase I | Disruption | |
| DNase I | Prevention | |
| DNase I, NucB | Disruption | |
| DNase I | Disruption & Prevention | |
| DNase I | Disruption | |
| DNase I, Varidase | Prevention | |
| DNase I L2 | Disruption & Prevention | |
| DNase I | Disruption & Prevention | |
| DNase I, λExonuclease | Disruption | |
| NucB | Disruption | |
| NucB | Disruption | |
| DNase I | Disruption | |
| DNase I | Disruption & Prevention | |
| DNase I, rhDNase I, NucB | Disruption & Prevention | |
| DNase I, DNase I L2, NucB | Disruption | |
| DNase I | Disruption | |
| NucB | Disruption | |
| NucB | Disruption | |
| NucB | Disruption | |
| NucB | Disruption | |
| DNase I, NucB | Disruption | |
| DNase I | Disruption | |
| rhDNase I | Prevention | |
| DNase I | Prevention |
Figure 2Schematic diagram of QSI prevents biofilm formation.
Quorum sensing inhibitors (QSIs), QSI sources, and action mode 35.
| QS inhibitor | Source of organism | Action mode |
|---|---|---|
| AHL-lactonase | AHLs degradation | |
| AHL-acylase | AHLs degradation | |
| AHL-oxidase | C4HSL and 30C12HSL | |
| AHL-oxidoreductase | 30C6HSL | |
| Lactones | Mimic AHL signals | |
| Halogenated Furanones | Mimic AHL signals and inhibit gene expression | |
| Vanillin | Vanilla beans extract (Vanilla | Interfere with AHL receptors. Inhibit C4-HSI C6-HSL, C8-HSL, 3-oxo-C8-HSL |
| Ajoene | Garlic extract ( | Blocks the QS-regulated productions of rhamnolipid resulting in phagocytosis of biofilm. Targets Gac/RSM part of QS and lowers the expression of regulatory RNAs in |
| Iberin | Horseradish extract ( | Inhibit expression of QS-regulated lasB-gfp and rhlA-gfp genes responsible for virulence factor in |
| Inhibit QS-mediated biofilm formation in P. aeruginosa | ||
| Garlic extract | Interferes with expression of QS-controlled virulence genes in | |
| Tumonoic acids | Blennothrix cantharidosmum | Compete with QS signals |
| Curcumin | Turmeric | Reduction of AHL production |
| 2-aminophenol | Synthetic | QS gene expression inhibitor |
| Triclosan | Synthetic | Inhibitor of the enoyl-ACP reductase |
| Furaly hydrazide | Synthetic | Mimic AHL signals |
| Furanone F3 and F4 | Synthetic | Reduce 3OC12HSL dependent QscR activity |
| Blastmycinolactol (Lactone) | Synthetic | Mimic AHL signals |
Figure 3US biological effects on biofilm cell (a) before and (b) after ultrasound probe is applied.
Figure 4US biological trends depending on different frequency and intensity levels.
Figure 5Biological effects of how biofilm on the implant surface removed by AMF (a) before AMF is applied, (b) heat generate with AMF process, and (c) biofilm removal by AMF.
Figure 6Schematic diagrams of how (a) high SFE and (b) low SFE coating surface influence the biofilm formation.
Biological effects on different US frequency and intensity 51-52.
| Frequency | Intensity | Bacterium | Effect of ultrasonic |
|---|---|---|---|
| 20 kHz | 0.2 ~ 2 W/cm2 | Competition of two bacterial responses: bacterial killing and bacterial declumping. | |
| 26 kHz | 0.2 ~ 0.5 W/cm2 | Cavitation cause bacteria damage. | |
| 28.5 kHz | 0.5 W/cm2 | After 48 hrs, no reduction of viable bacteria. | |
| 36 kHz | 60 ~ 190 W/L | US is able to use for biofilm removal, but not practical for large-scale application. | |
| 38 kHz | 5 ~ 20 W/cm2 | US is able to use for water disinfection. | |
| 67 kHz | 0.3 W/cm2 | Bacteria cells become susceptible to antibiotics through US treatment. | |
| 70 kHz | 0.2 ~ 2 W/cm2 | Low frequency and intensity US | |
| 70 kHz | 0.5 ~ 5 W/cm2 | Low US frequency with high intensity has better removal efficiency than high frequency. | |
| 500 kHz | 0.2 ~ 2 W/cm2 | High US frequency does not have high biocidal effect as low frequency with high intensity group. | |
| 800 kHz | 5 ~ 20 W/cm2 | High US frequency leads to high biocidal effect. Chemical disinfectant activity can be improved as well. | |
| 850 kHz | 0.2 ~ 2 W/cm2 | High US frequency leads to high biocidal effect. |